-
02.14.2024 Financial Results and Presentation Materials for the 2nd Quarter of the Fiscal Year ending June 2024
-
11.14.2023 Financial Results and Presentation Materials for the 1st Quarter of the Fiscal Year ending June 2024
-
11.02.2023 Notice Regarding a definitive distribution agreement for the Exclusive Sales of Penumbra's Peripheral Vascular Thrombus Aspiration Device in the Japanese Market
-
10.31.2023 Notice Regarding Establishment of Joint Venture Company (Subsidiary) with ELDORET HOSPITAL LTD
-
10.04.2023 Additional Agreement on Joint Research Agreement with Cuorips Inc.